Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061366) titled 'Clinical Assessment of Nutritional Therapy Awareness, Practice, and Collaboration for Liver Cirrhosis: An Internet Survey' on April 28.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co., Ltd.
Condition:
Condition - Cirrhosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To conduct a web-based questionnaire survey of physicians who routinely manage patients with liver cirrhosis, with the aim of clarifying the current status of nutritional therapy for liver cirrhosis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Physicians registered with the survey panel managed by Cross Marketing Inc. who have provided informed consent to participate in this survey. In addition, eligible participants are physicians who routinely manage patients with liver cirrhosis in their daily clinical practice.
Key exclusion criteria - None
Target Size - 250
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 03 Month 17 Day
Date of IRB - 2026 Year 04 Month 17 Day
Anticipated trial start date - 2026 Year 05 Month 19 Day
Last follow-up date - 2026 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070210
Disclaimer: Curated by HT Syndication.
